Therapeutic antibodies developer AnaptysBio has expanded its proprietary immunotherapy antibody portfolio to add multiple new combination therapies. The company developed a proprietary anti-PD-1 antibody, called ANB011, with key ...
Tags: AnaptysBio, Antibody Portfolio
Biopharmaceutical company Galena Biopharma has announced patent notification from the European Patent Office for pharmaceutical use of NeuVax (nelipepimut-S) as a vaccine for the prevention of relapse in breast cancer patients. The patent ...
Tags: Galena Biopharma, Neuvax
Johnson & Johnson has completed the acquisition of Aragon Pharmaceuticals, a pharmaceutical discovery and development company focused on drugs to hormonally-driven cancers. The Janssen Research & Development will manage compound ...
The European Commission has granted marketing authorization for Teva Pharmaceutical Industries' Lonquex (lipegfilgrastim) to commercialize in all twenty eight countries of the European Union plus Norway, Iceland and Liechtenstein. ...
Depomed has acquired US and Canadian rights to Archimedes Pharma’s Lazanda (fentanyl) nasal spray for $4m in cash for pain management in cancer patients (BTPc) 18 years of age and older. Leveraging Archimedes patented PecSys drug ...
Tags: Pharma's Lazanda, Medicine
Inspired by the streets of New York City, PINCH NYC is the newest urban lifestyle brand to hit the fashion world. PINCH NYC is a mash-up of New York City's high-end and urban designs meant to empower individual attitude, fashion expression ...
Tags: Apparel, Urban Lifestyle Brand
Researchers have developed an intelligent surgical knife that can help doctors identify if a tissue being cut is of cancerous nature or not, in turn enabling an accurate surgery. The knife, created by London's Imperial College ...
Tags: UK Researchers, Surgical Knife
Boston Biomedical has relocated its headquarters to Cambridge, Massachusetts with the opening of a new 64,000ft2 facility, in a bid to advance its efforts in discovering next generation of targeted cancer therapeutics. Commenting on the ...
Tags: Boston, Cambridge, Biomedical
US-based NanoString Technologies has announced that its Prosigna Breast Cancer Prognostic Gene Signature Assay offers better prognostic information in endocrine treated patients with HR+ node negative disease. NanoString Technologies said ...
Tags: Prognostic Information, Medicine
US-based NanoString Technologies has announced that its Prosigna Breast Cancer Prognostic Gene Signature Assay offers better prognostic information in endocrine treated patients with HR+ node negative disease. NanoString Technologies said ...
Tags: Prognostic Information, Medicine
Scientists at the Institute of Cancer Research, London, The Royal Marsden NHS Foundation Trust and Queen Mary University of London have developed a new breast cancer test, dubbed as PAM50, to help women avoid unnecessary chemotherapy. The ...
Tags: Breast Cancer, Chemotherapy
US-based Ambrx and China-based Zhejiang Medicine have collaborated to develop and commercialize ARX788, an antibody drug conjugate (ADC) targeting Her2-positive breast cancer. As per the deal, both the companies will advance the product ...
US-based Johnson & Johnson has agreed to buy Aragon Pharmaceuticals, a discovery and development company focused on drugs to treat hormonally-driven cancers, for nearly $1bn. As per the acquisition agreeement, an upfront cash payment of ...
Tags: Johnson&Johnson, Medicine
LED Medical Diagnostics, a developer of tissue fluorescence visualization technologies, has announced that its patented VELscope Vx oral examination device is presently involved in a Phase III study, which is sponsored by the University of ...
Tags: Oral Cancer Study, Medicine
Saladax Biomedical, US-based developer of diagnostic tests that optimize a patient's exposure to chemotherapy, has been certified as a registered CLIA Laboratory from the Office of Clinical Standards and Quality (OCSQ), a division of The ...
Tags: Laboratory Certification, Saladax